A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters

Crit Care Med. 2006 Mar;34(3):668-75. doi: 10.1097/01.CCM.0000201404.05523.34.

Abstract

Objective: Central venous catheters are the predominant cause of nosocomial bacteremia; however, the effectiveness of different antimicrobial central venous catheters remains uncertain. We compared the infection rate of silver-platinum-carbon (SPC)-impregnated catheters with rifampicin-minocycline (RM)-coated catheters.

Design: A large, single-center, prospective randomized study.

Setting: Twenty-two-bed adult general intensive care unit in a large tertiary metropolitan hospital in Brisbane, Australia (2000-2001).

Patients: Consecutive series of all central venous catheterizations in intensive care unit patients.

Interventions: Randomization, concealment, and blinding were carefully performed. Catheter insertion and care were performed according to published guidelines. Blood cultures were taken at central venous catheter removal, and catheter-tip cultures were performed by both roll-plate and sonication techniques. Pulsed field gel electrophoresis was used to establish shared clonal origin for matched isolates.

Measurements and main results: Central venous catheter colonization and catheter-related bloodstream infection were determined with a blinded technique using the evaluation of the extensive microbiological and clinical data collected and a rigorous classification system. Six hundred forty-six central venous catheters (RM 319, SPC 327) were inserted, and 574 (89%) were microbiologically evaluable. Colonization rates were lower for the RM catheters than SPC catheters (25 of 280, 8.9%; 43 of 294, 14.6%; p=.039). A Kaplan-Meier analysis that included catheter time in situ did not quite achieve statistical significance (p=.055). Catheter-related bloodstream infection was infrequent for both catheter-types (RM 4, 1.4%; SPC 5, 1.7%).

Conclusions: The SPC catheter is a clinically effective antimicrobial catheter; however, the RM catheter had a lower colonization rate. Both catheter types had low rates of catheter-related bloodstream infection. These results indicate that future studies will require similar rigorous methodology and thousands of central venous catheters to demonstrate differences in catheter-related bloodstream infection rates.

Publication types

  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Infective Agents, Local / therapeutic use*
  • Bacteremia / epidemiology
  • Bacteremia / etiology
  • Bacteremia / prevention & control
  • Carbon
  • Catheterization, Central Venous / adverse effects
  • Catheterization, Central Venous / instrumentation*
  • Catheters, Indwelling
  • Cross Infection / epidemiology
  • Cross Infection / etiology
  • Cross Infection / prevention & control
  • Equipment Contamination / prevention & control
  • Female
  • Humans
  • Logistic Models
  • Male
  • Middle Aged
  • Minocycline / therapeutic use*
  • Platinum
  • Prospective Studies
  • Queensland / epidemiology
  • Rifampin / therapeutic use*
  • Silver / therapeutic use*

Substances

  • Anti-Infective Agents, Local
  • Silver
  • Platinum
  • Carbon
  • Minocycline
  • Rifampin